ArticleActa biochimica et biophysica Sinica2022

ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer.

Hi-Ju Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.